Immunization of Humans with Polyribophosphate, the Capsular Antigen of Hemophilus influenzae, Type b
AUTOR(ES)
Anderson, Porter
RESUMO
In human volunteers, single injections of purified polyribophosphate elicited antibodies detectable by passive hemagglutination and by serum bactericidal and opsonizing activities against viable Hemophilus influenzae, type b. All three activities rose by 2 wk to maximal levels, at which they remained for at least 6 months. Doses of 1 μg elicited antibody responses in nearly all recipients; higher doses of the antigen, however, produced larger increases in titer. Booster doses of 1 μg given at 6 months did not further increase the antibody titers. A tuberculin-like response was often observed at the site of injections given intradermally.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=332926Documentos Relacionados
- Circulating polyribophosphate in Hemophilus influenzae, type b meningitis. Correlation with clinical course and antibody response.
- Human Serum Activities against Hemophilus influenzae, Type b
- Hemophilus influenzae, Type b, Antibody Frequencies Determined with Bactericidal and Radioimmunoassay Tests
- Pathophysiology of hemolysis in infections with Hemophilus influenzae type b.
- QUANTITATIVE DETERMINATION, IN TYPE-SPECIFIC ANTISERA TO HEMOPHILUS INFLUENZAE, OF THE ANTIBODY THAT CROSS-REACTS WITH ENCAPSULATED PNEUMOCOCCI1
